23andMe Privacy Reviewer’s Law Firm Discloses Work for Regeneron

WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of 23andMe’s customers’ genetic data while separately working for a major bidder for the assets, Regeneron Pharmaceuticals Inc., on unrelated matters.

The law firm won’t represent Regeneron on the drug developer’s $256 million offer for bankrupt genetic-testing firm 23andMe Holding Co.'s DNA data bank, it said in a supplemental disclosure filed Monday in the US Bankruptcy Court for the Eastern District of Missouri.

The firm last month was brought into the 23andMe bankruptcy to represent Washington University School of Law professor Neil Richards, the court-appointed ...